BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
금요일, 9월 25

Prime Medicine Inc

PRMENASDAQ
Trade with Public
Trade with Public
$3.07
-0.06-1.92%
가까이에: Sep 24, 5:00 PM EST
$3.43
0.3611.73%
시간외: 7:59 PM EST
PRO
변동 이유?:Prime Medicine shares are trading higher after the company announced the FD...
개요뉴스실적 전망이벤트목표가재무심리지분 현황배당금비교옵션주식 보고서

Prime Medicine Earnings & Forecasts

Prime Medicine (PRME) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

Quarterly Revenue (Billions)

Prime Medicine Guidance

Recent Earnings Results

MetricQ2 '26Q1 '26Q4 '25Q3 '25
Earnings Per Share (Non-GAAP)
Estimate$-0.25$-0.25$-0.25$-0.23
Actual$-0.24$-0.28$-0.24$-0.32
Surprise+4.00%-12.0%+4.00%-39.1%
Revenue
Estimate$1.8M$1.0M$2.2M$4.2M
Actual$1.2M$856000$838000$1.2M
Surprise-34.6%-16.0%—-71.2%
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
MetricQ3 '26EQ4 '26EQ1 '27EQ2 '27E
Earnings Per Share (Non-GAAP)
Consensus$-0.23$-0.22$-0.21$-0.22
Revenue
Consensus$3.1M$8.6M——
More with Benzinga EdgeGet Access

Earnings & Guidance News

PRO
Prime Medicine Q2 EPS $(0.24) Beats $(0.26) Estimate, Sales $1.154M Miss $1.295M Estimate

Prime Medicine (NASDAQ:PRME) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.26) by 7.69 percent. This is a 41.46 percent increase over losses of $(0.41) per share from
Benzinga Newsdesk

PRO
Prime Medicine Q1 EPS $(0.28) Misses $(0.25) Estimate, Sales $856.000K Miss $1.065M Estimate

Prime Medicine (NASDAQ:PRME) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.25) by 12 percent. This is a 30 percent increase over losses of $(0.40) per share from the
Benzinga Newsdesk

PRO
Prime Medicine Expects That Its Cash, Cash Equivalents And Investments Of $213.3M As Of September 30, 2025 Will Be Sufficient To Fund Its Operating Expenses And Capital Expenditure Requirements Into 2027.

Benzinga Newsdesk

PRO
Prime Medicine Q3 EPS $(0.32) Misses $(0.26) Estimate, Sales $1.225M Beat $1.026M Estimate

Benzinga Newsdesk

PRO
Prime Medicine Q2 EPS $(0.41) Misses $(0.39) Estimate, Sales $1.115M Beat $750.000K Estimate

Prime Medicine (NASDAQ:PRME) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.39) by 6.22 percent. This is a 10.87 percent increase over losses of $(0.46) per share from
Benzinga Newsdesk

PRO
Prime Medicine Q1 EPS $(0.40) Misses $(0.36) Estimate, Sales $1.45M Beat $1.05M Estimate

Prime Medicine (NASDAQ:PRME) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.36) by 11.11 percent. This is a 9.09 percent increase over losses of $(0.44) per share from
Benzinga Newsdesk

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

BenzingaBenzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved